Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40121-015-0070-1 http://scihub22266oqcxt.onion/10.1007/s40121-015-0070-1 C4471058!4471058!26032649     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infect+Dis+Ther 2015 ; 4 (2): 145-57 Nephropedia Template TP {{tp|p=26032649|t=2015. Tenofovir: What We Have Learnt After 7 5 Million Person-Years of Use |pdf=|usr=}}{{26032649}} gab.com Text Tenofovir: What We Have Learnt After 7 5 Million Person-Years of Use JO: Infect Dis Ther http://www.kidney.de/pget.php?&tw=1&pmid=26032649 #FOAvip Tenofovir was licensed for use in patients with HIV in 2001 and since then has become a firmly established anti-retroviral in both guidelines and routine practice. Data have been presented from many pivotal studies?informing on its efficacy, use, and adverse features?and there are also over 7.5 million patient-years of experience to date. We explore the data on this nucleotide reverse transcriptase inhibitor in HIV presented since 2008?focusing on efficacy, side effects, and utility.Electronic supplementary material: The online version of this article (doi:10.1007/s40121-015-0070-1) contains supplementary material, which is available to authorized users. Twit Text FOAVip Tenofovir: What We Have Learnt After 7 5 Million Person-Years of Use ????Infect Dis Ther http://www.kidney.de/pget.php?&tw=1&pmid=26032649 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26032649 #FOAvip English Wikipedia <ref>{{Cite pmid|26032649}}</ref> Tenofovir: What We Have Learnt After 7 5 Million Person-Years of Use #MMPMID26032649 Ustianowski A; Arends JE Infect Dis Ther 2015[Jun]; 4 (2): 145-57 PMID26032649show ga Tenofovir was licensed for use in patients with HIV in 2001 and since then has become a firmly established anti-retroviral in both guidelines and routine practice. Data have been presented from many pivotal studies?informing on its efficacy, use, and adverse features?and there are also over 7.5 million patient-years of experience to date. We explore the data on this nucleotide reverse transcriptase inhibitor in HIV presented since 2008?focusing on efficacy, side effects, and utility.Electronic supplementary material: The online version of this article (doi:10.1007/s40121-015-0070-1) contains supplementary material, which is available to authorized users. äTenofovir: What We Have Learnt After 7 5 Million Person-Years of Use (epmc).pdf DeepDyve Pubget Overpricing